Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · IEX Real-Time Price · USD
4.720
-0.160 (-3.28%)
At close: May 17, 2024, 4:00 PM
4.630
-0.090 (-1.91%)
After-hours: May 17, 2024, 4:07 PM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $208.15 million as of May 17, 2024. Its market cap has increased by 111.11% in one year.
Market Cap
208.15M
Enterprise Value
120.23M
1-Year Change
111.11%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $208.15M, a decrease of -52.74%. That is a compound annual growth rate of -21.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 205.10M | -3.30% |
May 16, 2024 | 212.10M | 0.62% |
May 15, 2024 | 210.80M | -1.59% |
May 14, 2024 | 214.20M | 10.53% |
May 13, 2024 | 193.80M | -11.67% |
May 10, 2024 | 219.40M | -9.34% |
May 9, 2024 | 242.00M | 1.64% |
May 8, 2024 | 238.10M | -4.22% |
May 7, 2024 | 248.60M | -4.35% |
May 6, 2024 | 259.90M | -1.48% |
May 3, 2024 | 263.80M | 1.54% |
May 2, 2024 | 259.80M | 0.97% |
May 1, 2024 | 257.30M | -3.52% |
Apr 30, 2024 | 266.70M | -6.29% |
Apr 29, 2024 | 284.60M | -1.35% |
Apr 26, 2024 | 288.50M | 8.70% |
Apr 25, 2024 | 265.40M | -2.82% |
Apr 24, 2024 | 273.10M | -0.76% |
Apr 23, 2024 | 275.20M | 5.72% |
Apr 22, 2024 | 260.30M | 3.25% |
Apr 19, 2024 | 252.10M | 0.48% |
Apr 18, 2024 | 250.90M | 0.52% |
Apr 17, 2024 | 249.60M | 4.09% |
Apr 16, 2024 | 239.80M | 2.22% |
Apr 15, 2024 | 234.60M | 17.07% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
INmune Bio | 216.82M |
Cellectis | 213.82M |
AVITA Medical | 213.36M |
Delcath Systems | 209.50M |
Inogen | 208.42M |
Conduit Pharmaceuticals | 207.46M |
Lineage Cell Therapeutics | 203.90M |
Profound Medical | 202.06M |